Cargando…
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model
BACKGROUND: Enhancer of zeste homolog 2 (EZH2) is considered an important driver of tumor development and progression by its histone modifying capabilities. Inhibition of EZH2 activity is thought to be a potent treatment option for eligible cancer patients with an aberrant EZH2 expression profile, t...
Autores principales: | Akpa, Chidimma Agatha, Kleo, Karsten, Oker, Elisabeth, Tomaszewski, Nancy, Messerschmidt, Clemens, López, Cristina, Wagener, Rabea, Oehl-Huber, Kathrin, Dettmer, Katja, Schoeler, Anne, Lenze, Dido, Oefner, Peter J., Beule, Dieter, Siebert, Reiner, Capper, David, Dimitrova, Lora, Hummel, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227222/ https://www.ncbi.nlm.nih.gov/pubmed/32408898 http://dx.doi.org/10.1186/s12885-020-06937-8 |
Ejemplares similares
-
DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations
por: Akpa, Chidimma Agatha, et al.
Publicado: (2019) -
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
por: Kleo, Karsten, et al.
Publicado: (2019) -
Functional and Pathological Roles of AHCY
por: Vizán, Pedro, et al.
Publicado: (2021) -
DNA methylation of AHCY may increase the risk of ischemic stroke
por: Zhao, Lei, et al.
Publicado: (2020) -
Chromatin capture links the metabolic enzyme AHCY to stem cell proliferation
por: Aranda, Sergi, et al.
Publicado: (2019)